Neurocrine Biosciences (NASDAQ:NBIX): Q4 Non-GAAP EPS of $1.05 beats by $0.30; GAAP EPS of $0.35 misses by $0.41.
Revenue of $244.1M (+85.8% Y/Y) beats by $12.56M.
https://seekingalpha.com/news/3538160-neurocrine-biosciences-eps-beats-0_30-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.